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Abstract: BACKGROUND: Previous studies have shown that some viral infections may be triggers for autoimmune
diseases. The role of viral infections in the etiopathogenesis of pemphigus has also been investigated. 
OBJECTIVES: To investigate the relationship between pemphigus and the hepatitis B and C virus infections. 
METHODS: This retrospective study included 62 patients with pemphigus and 50 healthy controls of matching ages
and genders. The control group included relatives who accompanied the orthopedic patients to the hospital but
had no history of systemic and/or autoimmune diseases. 
RESULTS: The group of patients with pemphigus was composed of 43 (69.3%) females and 19 (29.7%) males, and
the mean age was 48.08 ± 15.38. The hepatitis C virus antibody was negative in all of the patients. Hepatitis B sur-
face antigen (HBsAg), hepatitis B surface antibody (HBsAb), or both, were studied in 44 of the 62 patients. Two
(4.3%) of these patients were positive for HBsAg and found to have HBV infection. Fourteen of them were HBsAb
positive. Two (4%) of the 50 control subjects showed hepatitis C virus antibody positivity, while only 1 (2%)
patient with pemphigus displayed HBsAg positivity. There was no statistically significant difference between the
two groups for hepatitis B and C virus infections. 
CONCLUSIONS: This study does not support an association between pemphigus and hepatitis B and/or C virus
infections.
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INTRODUCTION
Pemphigus is a rare autoimmune disease of the
skin and mucous membranes. Previous studies have
shown that some viral infections may be triggers for
autoimmune diseases in patients with genetic suscep-
tibility to them.1 The role of viral infections in the etio-
pathogenesis of pemphigus has also been investiga-
ted.2 The role of HCV in the etiopathogenesis of secon-
dary anti-phospholipid syndrome, Sjögren syndrome,
autoimmune trombocytic purpura and cryoglobuline-
mia, have been reported.3,4 Similarly, the mechanisms
involved in HBV infection have been proposed as a
trigger in some autoimmune diseases such as diabetes
mellitus type 1, polyarteritis nodosa and vitiligo.5,6,7
However, there are few studies that evaluate the rela-
tionship between pemphigus and HCV and HBV
infections.8-11 The purpose of this study is to investiga-
te the frequency of HCV and HBV infections in our
patients who had recently been diagnosed with
pemphigus.
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MATERIALS AND METHODS
Sixty-two patients with a new diagnosis of
pemphigus were included in this retrospective study.
In addition to clinical and histopathological findings,
diagnosis of pemphigus had been confirmed through
direct immunofluorescent microscopy. The control
group was composed of 50 subjects of matching ages
and genders, gathered from among the relatives of the
orthopedic patients. The controls all had a negative
history for systemic and/or autoimmune diseases and
had provided verbal informed consent for the study.
In our departments, all patients with pemphigus are
screened for HBsAg, HBsAb and anti-HCV, using
ELISA, before starting appropriate immunosuppressi-
ve therapy, since this treatment can exacerbate viral
infections such as HBV and HCV infections. The con-
trol group was set up after the decision had been
taken to conduct a retrospective study. This group was
informed about viral hepatitis and the vaccination for
HBV, and those who were found to be eligible for the
study were included. The study used their patient
records or face-to face interviews to obtain their ages,
genders, serologic test results, family history of HBV
and HCV occurrences and the risk factors for HBV
and HCV infections, such as blood transfusion, hemo-
dialysis, past operations, transplantation, ear piercing,
dental surgery and similar trauma histories. The sero-
logical test results of pemphigus patients were acqui-
red from the database of our patients’ records.
Statistical Analysis:
SPSS Statistics 17.0 for Windows was used for
statistical analysis. The distribution of the data was
tested using Kolmogrov-Smirnov and Anova tests.
The independent test was used for the analysis of the
data; p<0.05 was considered to be significant.
RESULTS
The study group involved 62 pemphigus
patients, including 43 women and 19 men (age range:
10-78 years, mean 48.08 ± 15.38) and 50 controls with
35 women and 15 men (age range 18-82 years, mean
48.56 ± 15.50). Of the 62 pemphigus patients, 57 (92%)
had pemphigus vulgaris, 2 (3.2%) had pemphigus
foliaceus, 2 (3.2%) had pemphigus vegetans and 1
(1.6%) had pemphigus erythematosus.
Anti-HCV Ab was negative in all of the pemp-
higus patients. Among this group, only one had a
family member with HCV infection. In the control
group, anti-HCV test results were found to be positi-
ve in 2 (4%) individuals who were also positive for
HCV-RNA, confirming HCV infection. We did not
find a statistically significant difference between the
two groups for HCV infection (p=0.114) (Table 1).  In
the assessment of risk factors, only one of the HCV-
positive controls declared a past surgery, but that had
been more than three months before and was not
interpreted as a risk factor.
We could only evaluate HBV screening in 44 of
the 62 pemphigus patients because of temporary tech-
nical problems. Fourteen (31.8%) of the patients were
HBsAb positive and 2 (4.3%) were HBsAg positive,
denoting HBV infection.  We did not find any of the
risk factors in the two pemphigus patients with
Hepatitis B infection (Table 2). In the control group, 14
(28%) individuals were HBsAb positive and 1 (2%)
was HBsAg positive. There were no statistically signi-
ficant differences between the two groups for HBsAb
and HBsAg positivity (p=0.848, p=0.526, respectively)
(See Table 1). We did not encounter any of the risk fac-
tors in the patients and controls with positive serolo-
gy for HBV.
DISCUSSION
Pemphigus is an autoimmune disease characte-
rized by painful oral mucosa erosions and fragile bul-
lous skin lesions. The IgG-type antibodies targeting
the keratinocytic antigens, desmoglein 1 and desmo-
glein 3, play a major role in the etiopathogenesis of the
disease, by inducing acantholysis.12
Although there is some conflicting evidence,
the hypothesis that some infections trigger autoimmu-
ne disease in genetically predisposed individuals is
still up to date. The association of cryoblobulinemia
and Sjögren syndrome with chronic HCV infections is
well-known. Furthermore, the antinuclear, anti-
smooth muscle, anticardiolipin and antithyroid anti-
body positivity accompanying these infections, sup-
port this view.4
The exact pathogenetic mechanism involved in
HCV and autoimmunity is not known. However, this
microorganism has been incriminated in the elimina-
tion of tolerance that is protected from autoimmunity.13
In addition, the activation of B lymphocytes resulting
from HCV residence on these cells has been seen as
responsible for autoimmunity.14
Some studies have investigated the association
of HCV with autoimmune diseases. Agmon-Levin et
al. found that the frequency of HCV infection in 1,322
patients with various autoimmune diseases was signi-
ficantly higher (8.7%), compared with the control
group (%0.4). In this study, the prevalence of HCV
was found to be 14% among the pemphigus vulgaris
patients, and the authors emphasized a new associa-
tion between HCV and pemphigus.8 The prevalence of
HBV infection in anti-HCV-positive pemphigus folia-
ceus patients was also found to be considerable.10 Sagi
et al. found that the frequency of HBV, HCV, H. pylo-
ri, T. gondii, T. pallidum and CMV was significantly
higher than in the control group in pemphigus and
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TABLE 1: The comparison of HBsAg, Anti HBsAg and Anti-HCV test results and the existence of risk factors for
hepatitis virus infections between the pemphigus group and the control group
Pemphigus n % Control n % P
patients group 
Anti-HCV Positive: 0 0 Positive: 2 4 0.114
Negative: 62 100 Negative: 48 96
HBsAg Positive: 2 4.56 Positive: 1 2 0.526
Negative: 42 95.44 Negative: 49 98
AntiHBsAg Positive: 14 31.8 Positive: 14 28 0.848
Negative: 30 68.2 Negative: 36 72
Risk Factors Abnormality in hepatic Yes: 2 3.2 Yes: 3 6 0.932
function tests No: 60 96.8 No: 47 94
Hepatitis B and/ Yes: 1 1.6 Yes: 0 0 0.159
or C virus infection No: 61 98.4 No: 50 100
in family members
Past operation Yes: 14 22.6 Yes: 10 20 0.960
(operations done No: 48 77.4 No: 40 80
under local or general 
anesthesia)
Ear piercing Yes: 11 17,75 Yes: 13 26 0.294
No: 51 82,25 No: 37 76
Blood transfusion Yes: 2 3.2 Yes: 1 2 0,381
No: 60 96.8 No: 49 98
Hemodialysis Yes: 0 0 Yes: 0 0 1
No: 62 100 No: 50 100
Transplantation Yes: 0 0 Yes: 0 0 1
No: 62 100 No: 50 100
Blood transfusion or Yes: 0 0 Yes: 0 0 1
past operation in the No: 62 100 No: 50 100
last 3 months
TABLE 2: There were no risk factors in the two pemphigus patients with Hepatitis B infection
Patient 1 Patient 2
Risk factors Hepatitis B  infection in family members Absent Absent
Past operation (operations done under local Absent Absent
or general anesthesia)
Ear piercing Absent Absent
Blood transfusion Absent Absent
Hemodialysis Absent Absent
Transplantation Absent Absent
Blood transfusion or past operation in the last 3 months Absent Absent
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bullous pemphigoid patients.9 In accordance with
these results, a pemphigus case has been reported
after a hepatitis B vaccination.11 However, there are
also opposing results: Rosa et al. did not find any
association between HCV infection and pemphigus in
126 patients with fogo selvage, in their study group.10
In terms of our findings, although the prevalence of
HCV infection was 4% in the control group, none of
our 62 pemphigus patients had HCV infection.
Nevertheless, the prevalence of HBV infection in our
pemphigus patients was 4.3%, while it was 2 % in the
control group. There was no statistically significant
difference between the two groups for HBV and HCV
infections. According to the surveys, 1% of the Turkish
population has been found to be infected by HCV, and
2.7% by HBV. 15 The results are also slightly different
from the general population. We believe that the
results obtained may have been caused by the small
numbers in our study groups. If the number of
patients and controls were higher, the prevalence of
these viral infections would probably be closer to the
prevalence within the general population.
CONCLUSION
The controversy surrounding the role of viral
infections in the etiopathogenesis of autoimmune
diseases still exists today. However, the findings of
our study do not support any association between
pemphigus and HBV and/or HCV infections. q
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